reference/34800734

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34800734

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	2375-2548
issueIdentifier	40
pageRange	eabo8043-
publicationName	Science Advances
startingPage	eabo8043
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cf5b9d5995507abc870f68cd20a978d7
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b6f06e6fa93f7058caa73afede066042 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2611887479207c21a53fde511ff4ec76 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e7f5a22d98380ed12ab7f304c6cff6f2
bibliographicCitation	Piunti A, Meghani K, Yu Y, Robertson AG, Podojil JR, McLaughlin KA, You Z, Fantini D, Chiang M, Luo Y, Wang L, Heyen N, Qian J, Miller SD, Shilatifard A, Meeks JJ. Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma. Sci Adv. 2022 Oct 07;8(40):eabo8043. PMID: 36197969; PMCID: PMC9534493.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec37cebb8fb47eed586e87792c3ccbdb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49da7535423cac2421cc1c3106827f59 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7858-0170 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7490-2854 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ccbeb101b60dd27ad4cdd0ade1f23003 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2839-596X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b794684e7f6c20bda8337dabdb1c92ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6092-7209 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9556-0718 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44ea774ea7c0a6d5bdeed5aaeedeaa90 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b17b670d1fcf0ecd0a8e3b16897cd60 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5444-5510 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0441-0747 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5818-8515 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b2591139bf6c5f2aac73da38c04c79d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3344-8755
date	2022-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/36197969 https://pubmed.ncbi.nlm.nih.gov/PMC9534493 https://doi.org/10.1126/sciadv.abo8043
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43628 https://portal.issn.org/resource/ISSN/2375-2548
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma
discusses	http://id.nlm.nih.gov/mesh/M000638916 http://id.nlm.nih.gov/mesh/M0476035 http://id.nlm.nih.gov/mesh/M000613664 http://id.nlm.nih.gov/mesh/M0003416
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001749Q000378 http://id.nlm.nih.gov/mesh/D002295
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D000076983 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D002273 http://id.nlm.nih.gov/mesh/D000071221Q000378 http://id.nlm.nih.gov/mesh/D045744
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c3addd02e769f33d86f94bb13502ccd5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7173 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7053 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14056

Total number of triples: 55.